Conclusion
Significant morbidity and mortality are attributed to LVAD thrombosis, which are exasperated by prothrombotic conditions manifested in COVID-19 infections. LVAD thrombosis due to COVID -19 is underreported .For the best clinical outcomes, a high level of clinical suspicion must be present to diagnose and treat this problem effectively and efficiently.